Russell J. Cox
2016 - Jazz Pharmaceuticals
In 2016, Russell J. Cox earned a total compensation of $2.9M as Executive Vice President and COO at Jazz Pharmaceuticals, a 12% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $313,200 |
|---|---|
| Option Awards | $902,696 |
| Salary | $571,154 |
| Stock Awards | $1,110,239 |
| Other | $5,622 |
| Total | $2,902,911 |
Cox received $1.1M in stock awards, accounting for 38% of the total pay in 2016.
Cox also received $313.2K in non-equity incentive plan, $902.7K in option awards, $571.2K in salary and $5.6K in other compensation.
Rankings
In 2016, Russell J. Cox's compensation ranked 3,313th out of 14,075 executives tracked by ExecPay. In other words, Cox earned more than 76.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,313 out of 14,075 | 77th |
Division Manufacturing | 1,150 out of 5,486 | 79th |
Major group Chemicals And Allied Products | 344 out of 1,900 | 82nd |
Industry group Drugs | 249 out of 1,543 | 84th |
Industry Pharmaceutical Preparations | 194 out of 1,173 | 84th |
Source: SEC filing on June 20, 2017.
Cox's colleagues
We found five more compensation records of executives who worked with Russell J. Cox at Jazz Pharmaceuticals in 2016.
2016
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2016
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2016
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2016
Karen Smith
Jazz Pharmaceuticals
Chief Marketing Officer
2016
Michael Miller
Jazz Pharmaceuticals